Pharmaceutical manufacturer.
Policy issues relating to a proposed FDA regulation on generic drug labeling. 
Policy issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." 
Policy issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS